Krishna Vaddi serves as Executive at Prelude Therapeutics Inc, where they oversee executive responsibilities. Since joining the company, Krishna Vaddi has executed 9 insider transactions totaling $175.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 4, 2026 involved receiving (via award) 837,000 shares valued at $0.
Krishna Vaddi currently holds 837,000 shares of Prelude Therapeutics Inc (PRLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Krishna Vaddi has been a net buyer of PRLD stock. They have purchased $175.0K and sold $0 worth of shares.
Krishna Vaddi's most recent insider trade was on Feb 4, 2026, when they sold 837,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $5.31 |
| Discretionary |
| May 24, 2023 | PRLD | $5.0K | Purchase | 1,000 | $5.01 | Discretionary |
| May 23, 2023 | PRLD | $66.7K | Purchase | 11,856 | $5.63 | Discretionary |
| Dec 20, 2022 | PRLD | $98.4K | Purchase | 19,188 | $5.13 | Discretionary |
| Dec 13, 2021 | PRLD | $97.0K | Award | 8,000 | $12.13 | Discretionary |
| Sep 29, 2020 | PRLD | $0 | Conversion | 32,876 | $N/A | Discretionary |
| Sep 29, 2020 | PRLD | $0 | Conversion | 32,876 | $N/A | Discretionary |
| Sep 29, 2020 | PRLD | $0 | Conversion | 101,477 | $N/A | Discretionary |